Clinical Trial Update: Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD) [Phase 1]

View source ↗

Summary

A Phase 1 double-blind study evaluated ketamine therapy with and without naltrexone in treatment-resistant depression. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• Naltrexone (Naltrexone)

Snippet

Sponsor: Stanford University | Conditions: Depression | Phase 1 | Status: COMPLETED